Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
24.75
+0.01 (0.04%)
May 19, 2026, 4:00 PM EDT - Market closed

Avanos Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1595227321,0361,2591,671
Market Cap Growth
104.97%-28.70%-29.35%-17.74%-24.67%-23.98%
Enterprise Value
1,232542.61773.931,1361,3901,726
Last Close Price
24.7511.2315.9222.4327.0634.67
PE Ratio
----25.29-
Forward PE
21.5211.7010.1015.6515.8923.16
PEG Ratio
-2.700.482.340.891.30
PS Ratio
1.620.741.061.541.842.85
PB Ratio
1.480.670.880.840.981.32
P/TBV Ratio
1.480.670.880.850.991.33
P/FCF Ratio
154.5212.108.8370.9417.5825.21
P/OCF Ratio
31.586.987.2731.9713.8519.14
EV/Sales Ratio
1.720.771.131.692.032.94
EV/EBITDA Ratio
22.03--22.5816.71-
EV/EBIT Ratio
75.10--270.4039.16-
EV/FCF Ratio
164.2312.599.3477.7919.4226.03
Debt / Equity Ratio
0.150.140.180.150.200.14
Debt / EBITDA Ratio
---4.163.33-
Debt / FCF Ratio
18.453.002.0514.323.872.83
Net Debt / Equity Ratio
0.090.050.080.100.120.05
Net Debt / EBITDA Ratio
-3.10-1.73-0.182.411.79-98.57
Net Debt / FCF Ratio
9.710.910.758.322.091.04
Asset Turnover
0.670.630.480.390.400.36
Inventory Turnover
2.472.422.031.991.991.75
Quick Ratio
1.291.171.450.981.551.79
Current Ratio
2.482.152.372.083.273.07
Return on Equity (ROE)
-9.54%-9.07%-37.42%-0.78%1.68%-2.45%
Return on Assets (ROA)
-6.25%-6.09%-26.66%0.30%1.69%-1.75%
Return on Invested Capital (ROIC)
-7.75%-7.81%-32.21%0.36%2.00%-2.07%
Return on Capital Employed (ROCE)
-6.90%-6.50%-32.39%0.28%2.32%-2.63%
Earnings Yield
----3.95%-
FCF Yield
0.65%8.26%11.33%1.41%5.69%3.97%
Buyback Yield / Dilution
-0.92%-0.65%1.29%1.48%2.67%-1.67%
Total Shareholder Return
-0.92%-0.65%1.29%1.48%2.67%-1.67%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q